Zydus Lifesciences Ltd.
BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
927.15
-19.95
(-2.11%)
< Home
< Back
Zydus Lifesciences Ltd. News
>>
Zydus Lifesciences informs about loss of share certificate
>>
Zydus Lifesciences informs about press release
>>
Zydus Lifesciences gets exclusive marketing rights for innovative prognostic test ‘CanAssist Breast’
>>
Zydus Lifesciences informs about outcome of board meeting
>>
Zydus Lifesciences reports 83% fall in Q2 consolidated net profit
>>
Zydus Lifesciences - Quaterly Results
>>
Zydus Lifesciences - Quaterly Results
>>
Zydus Lifesciences - Quaterly Results
>>
Zydus Lifesciences gets final nod to market Bisoprolol Fumarate and Hydrochlorothiazide tablets
>>
Zydus Lifesciences informs about press release
<<
<
55
56
57
...168
>
>>